Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07447687 · ClinicalTrials.gov registry record · Phase 1
Soy Tomato Juice to Improve Outcomes in Pancreatitis
A Phase 1 study of Chronic Pancreatitis and Recurrent Acute Pancreatitis, sponsored by Ohio State University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT07447687: Recruiting Phase 1 study of Chronic Pancreatitis and Recurrent Acute Pancreatitis, sponsored by Ohio State University.
NCT07447687 is a Phase 1 study of Chronic Pancreatitis and Recurrent Acute Pancreatitis that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 35 participants, below the 688-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07447687, a Phase 1 study of Chronic Pancreatitis and Recurrent Acute Pancreatitis, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
This goal of this clinical trial is to see if people with recurrent acute pancreatitis or chronic pancreatitis can tolerate and regularly drink a tomato juice beverage. Researchers will also measure inflammation and ask participants to report how they feel. Everyone in the study will receive the tomato juice drink, and both participants and researchers will know what is being taken. The investigators expect the drink will be well tolerated, may lower inflammation, and may improve participant-reported symptoms and quality of life.
Primary Outcome
Safety will be evaluated by monitoring adverse events throughout the study. Information will be collected through routine study assessments, including participant interactions, diary entries, vital signs, and standard clinical laboratory testing. Adverse events will be graded using the Common Terminology Criteria for Adverse Events (CTCAE v.5.0). For this study, we define a dose-limiting toxicity (DLT) as the appearance of any adverse event reaching Grade 3-5 toxicity or that otherwise prevents
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Soy-tomato juice product
- DIETARY_SUPPLEMENT Will include a soy-tomato juice product to be consumed during the 4 week intervention phase. A total of about 12 ounces (administered in two small cans) of the juice will be consumed
Study Locations (1)
Ohio
- The Ohio State University Wexner Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2026-02 |
| Est. Completion | 2028-06 |
| Phase | Phase 1 |
What NCT07447687 shows while recruiting
NCT07447687 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 688-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Chronic Pancreatitis appearing as the primary indexed condition, and to 2 interventions - of which Soy-tomato juice product is the first listed.
NCT07447687 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07447687 about?
NCT07447687 is a clinical study titled "Soy Tomato Juice to Improve Outcomes in Pancreatitis". This goal of this clinical trial is to see if people with recurrent acute pancreatitis or chronic pancreatitis can tolerate and regularly drink a tomato juice beverage. Researchers will also measure inflammation and ask participants to report how they feel. Everyone in the study will receive the tom...
What is the current status of trial NCT07447687?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 35 participants. The study started on 2026-02. Estimated completion is 2028-06.
What conditions does trial NCT07447687 study?
This clinical trial studies the following conditions: Chronic Pancreatitis, Recurrent Acute Pancreatitis.
What interventions are being tested in trial NCT07447687?
The interventions under investigation include: Soy-tomato juice product (DIETARY_SUPPLEMENT), Will include a soy-tomato juice product to be consumed during the 4 week intervention phase. A total of about 12 ounces (administered in two small cans) of the juice will be consumed (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07447687?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07447687 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pancreatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07447687's enrollment target sits among peer trials
35 29th of 42 higher than 13 of 42 other Chronic Pancreatitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pancreatitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT
RECRUITING · Phase 1
-
Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis
RECRUITING · Phase 1
-
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
RECRUITING · Phase 1
-
Carbon Monoxide-Saturated Medium for Islet Isolation
COMPLETED · Phase 1
-
Trial of Indomethacin in Chronic Pancreatitis
COMPLETED · Phase 1
-
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia